The Evolving Treatment Landscape of DMD

An expert discusses the evolving treatment landscape of Duchenne Muscular Dystrophy (DMD), highlighting advances in gene therapy, exon-skipping agents, and novel corticosteroids that aim to slow disease progression, improve muscle function, and enhance quality of life, while emphasizing the growing role of personalized medicine and early intervention in optimizing long-term outcomes.